Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review.
Lombardo G, Lechanteur C, Briquet A, Seidel L, Willems E, Servais S, Baudoux E, Kerre T, Zachee P, Herman J, Janssen A, Muller J, Baron F, Beguin Y. Lombardo G, et al. Among authors: herman j. Stem Cell Res Ther. 2024 Dec 3;15(1):461. doi: 10.1186/s13287-024-04064-w. Stem Cell Res Ther. 2024. PMID: 39627816 Free PMC article. Clinical Trial.
Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.
Fortman D, Wang H, VanderWeele R, Evans T, Herman JG, Rhee J, Reyes V, McLaughlin B, Wozniak A, Somasundaram A, Mekhail T, Socinski MA, Schulze K, Villaruz LC. Fortman D, et al. Among authors: herman jg. Clin Lung Cancer. 2024 Oct 30:S1525-7304(24)00231-6. doi: 10.1016/j.cllc.2024.10.014. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39578170 Free article. No abstract available.
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma.
Hill CS, Parkinson R, Jaffee EM, Sugar E, Zheng L, Onners B, Weiss MJ, Wolfgang CL, Cameron JL, Pawlik TM, Rosati L, Le DT, Hacker-Prietz A, Lutz ER, Schulick R, Narang AK, Laheru DA, Herman JM. Hill CS, et al. Among authors: herman jm. Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03561-2. doi: 10.1016/j.ijrobp.2024.10.039. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39547453
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy.
Sanford NN, Narang AK, Aguilera TA, Bassetti MF, Chuong MD, Erickson BA, Goodman KA, Herman JM, Intven M, Kilcoyne A, Kim H, Paulson E, Reyngold M, Tsai S, Tchelebi LT, Tuli R, Versteijne E, Wei A, Wo JY, Zhang Y, Hong TS, Hall WA. Sanford NN, et al. Among authors: herman jm. Int J Radiat Oncol Biol Phys. 2024 Nov 5:S0360-3016(24)03516-8. doi: 10.1016/j.ijrobp.2024.10.026. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39510320 Review.
3-nitropyridine analogues as novel microtubule-targeting agents.
Herman J, Vanstreels E, Bardiot D, Prota AE, Gaillard N, Gao LJ, Vercruysse T, Persoons L, Daems T, Waer M, Herdewijn P, Louat T, Steinmetz MO, De Jonghe S, Sprangers B, Daelemans D. Herman J, et al. PLoS One. 2024 Nov 7;19(11):e0307153. doi: 10.1371/journal.pone.0307153. eCollection 2024. PLoS One. 2024. PMID: 39509402 Free PMC article.
Body composition as a biomarker for assessing future lung cancer risk.
Wang J, Leader JK, Meng X, Yu T, Wang R, Herman J, Yuan JM, Wilson D, Pu J. Wang J, et al. Among authors: herman j. medRxiv [Preprint]. 2024 Oct 15:2024.10.14.24315477. doi: 10.1101/2024.10.14.24315477. medRxiv. 2024. PMID: 39484267 Free PMC article. Preprint.
2,358 results